The Premise of Capsid Assembly Modulators Towards Eliminating HBV Persistence.

Leda BassitFranck AmblardDharmeshkumar J PatelNicolas BiteauZhe ChenMahesh KasthuriShaoman ZhouRaymond F Schinazi

Published in: Expert opinion on drug discovery (2023)

Mono- or combination therapy, including CAMs with other HBV drugs, may potentially eliminate hepatitis B infections. Nevertheless, more data on their potential effect on HBV elimination is needed, especially when used daily for 6-12 months.

Keyphrases

hepatitis b virus
combination therapy
liver failure
small molecule
physical activity
electronic health record
big data
machine learning
risk assessment
climate change
data analysis
artificial intelligence
drug induced
deep learning